The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group, focused ...

A Mayo Clinic study shows current guidelines miss most people with familial hypercholesterolemia, an inherited cause of high ...

A large Mayo Clinic study shows that current guidelines fail to detect nearly 90% of people with familial hypercholesterolemia, a common inherited cause of dangerously high cholesterol. Many affected ...

Ocular manifestations like xanthelasma and arcus corneae are early indicators of high cholesterol and increased ...

The update addresses major gaps in basic insurance, sharply reducing costs for drugs used to treat triple-negative breast cancer, pancreatic cancer, lung cancer, and other serious conditions.

PRECISE confirms that hereditary cancers and kidney-related genetic diseases are under review for potential national genetic ...

Heart doctors are capturing images of the inside of heart arteries, helping them watch plaque respond to cholesterol drugs in ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the successful inclusion of all five of the Company's ...

Massachusetts Institute of Technology professor Phillip Sharp co-founded Alnylam with several others in 2002. It wasn't Sharp ...

Third Largest Global Market for Cardiovascular Prevention Represents Significant Global Growth Opportunity for NEXLETOL – ANN ARBOR, Mich., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) ...

“During a heart screening, we’re also thinking about how your family history impacts your risk,” Tran said. “If you have a ...